Evidence map›Paper›PMID 34226573›Full record

ArticleScientific reports2021

Strategic approach of multifaceted antibacterial mechanism of limonene traced in Escherichia coli.

Akshi Gupta, Ebenezer Jeyakumar, Rubina Lawrence

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Akshi GuptaDepartment of Industrial Microbiology, Jacob Institute of Biotechnology and Bioengineering, Technology and Sciences, Sam Higginbottom University of Agriculture, Prayagraj (Allahabad), Uttar Pradesh, 211007, India.
Ebenezer JeyakumarDepartment of Industrial Microbiology, Jacob Institute of Biotechnology and Bioengineering, Technology and Sciences, Sam Higginbottom University of Agriculture, Prayagraj (Allahabad), Uttar Pradesh, 211007, India.
Rubina LawrenceDepartment of Industrial Microbiology, Jacob Institute of Biotechnology and Bioengineering, Technology and Sciences, Sam Higginbottom University of Agriculture, Prayagraj (Allahabad), Uttar Pradesh, 211007, India. rubinalawrence@gmail.com.
Sam Higginbottom Institute of Agriculture · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial potential of Limonene against Multi Drug Resistant (MDR) pathogens was studied and mechanism explored. Microscopic techniques viz. Fluorescent Microscopy (FM), Scanning Electron Microscopy (SEM), and Transmission Electron Microscopy (TEM) indicated membrane disruption, cellular leakage and cell death of Escherichia coli (E. coli) cells when treated with limonene. Leakage of intracellular proteins, lipids and nucleic acid confirmed membrane damage and disruption of cell permeability barrier. Further, release of intracellular ATP, also suggested disruption of membrane barrier. Interaction of limonene with DNA revealed its capability in unwinding of plasmid, which could eventually inhibit DNA transcription and translation. Differential expression of various proteins and enzymes involved in transport, respiration, metabolism, chemotaxis, protein synthesis confirmed the mechanistic role of limonene on their functions. Limonene thus can be a potential candidate in drug development.

Indexed as

Anti-Bacterial AgentsCell MembraneCell Membrane PermeabilityDrug Resistance, Multiple, BacterialEscherichia coliGene Expression Regulation, BacterialLimoneneLipidsMicrobial Sensitivity TestsMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNucleic AcidsAnti-Bacterial AgentsLimoneneLipidsNucleic Acids

Identifiers

PMID34226573
PMCPMC8257740
OpenAlexW3178521560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.